{"id": "1371472136129413121", "creation": 1615819412.0, "user_id": "1219650539086065664", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 0, "quote_count": 0}}, "text": "\ud83c\uddeb\ud83c\uddf7 @sanofipasteur &amp; \ud83c\uddfa\ud83c\uddf8 @TranslateBio announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA #vaccine candidate against SARS-CoV-2, the virus that causes #COVID19. The interim results are expected in Q3 2021\u27a1\ufe0fhttps://t.co/5DKMiCRec2 #FrenchHealthcare https://t.co/Eg3DxPozX6", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#FRENCHHEALTHCARE"]}